Skip to main content

Advertisement

Table 1 Baseline characteristics of patients categorized according to the presence of CAD (n = 120)

From: Postchallenge responses of nitrotyrosine and TNF-alpha during 75-g oral glucose tolerance test are associated with the presence of coronary artery diseases in patients with prediabetes

Characteristic CAD (n = 65) Non-CAD (n = 55) P values
Age (yrs) 64.9 ± 10.6* 59.1 ± 9.6 < 0.05
Sex (F/M) 13/52* 26/29 < 0.05
SBP (mmHg) 132 ± 22 129 ± 19 0.238
DBP (mmHg) 81 ± 14 77 ± 12 0.163
Body mass index (kg/m2) 26.6 ± 3.3 25.9 ± 4.8 0.835
Waist-to-hip ratio 0.85 ± 0.10 0.83 ± 0.15 0.729
Fasting plasma glucose (mg/dl) 103.3 ± 12.3 101.7 ± 13.3 0.527
Impaired fasting glucose [n (%)] 35 (53.9%) 30 (54.5%) 0.938
HbA1C (%) 5.4 ± 0.9 5.2 ± 0.7 0.725
Family history of CAD [n (%)] 12 (18.4%) 8 (14.5%) 0.815
Past history [n (%)]    
   Hypercholesterolemia 34 (52.3) 28 (51.0) 0.078
   Hypertension 47 (72.3) 37 (67.2) 0.159
   Alcohol intake 22 (33.8) 22 (40.0) 0.875
   Current smoker 18 (27.7) 14 (25.4) 0.753
Lipid profiles (mg/dL)    
   Total cholesterol 215 ± 48 208 ± 41 0.238
   LDL cholesterol 127 ± 37 119 ± 42 0.105
   HDL cholesterol 41 ± 10 43 ± 12 0.369
   Triglycerides 217 ± 126 209 ± 138 0.245
Concomitant medication [n (%)]    
   Aspirin/Clopidogrel 37 (56.9) 25 (45.4) 0.095
   β Adrenergic blockers 18 (27.7) 16 (29.1) 0.358
   Calcium channel blockers 44 (67.7) 36 (65.4) 0.259
   ACE inhibitor/ARB 29 (44.6) 23 (41.8) 0.347
   Diuretics 24 (36.9) 18 (32.7) 0.135
   Statin 33 (50.8) 26 (47.2) 0.085
   Fibrate 5 (7.7) 4 (7.3) 0.468
  1. *P < 0.05; ACE = angiotensin-converting enzyme; ARB: angiotensin II receptor blockers; BMI: body mass index; HbA1C: hemoglobin A1C; HDL: high density lipoprotein; LDL: low density lipoprotein